ANDA 74359, held by Watson Labs. Aspirin; Butalbital; Caffeine; Codeine Phosphate.
As of Nov 15, 2026, ANDA 74359 (Butalbital, Aspirin, Caffeine, And Codeine Phosphate), held by Watson Labs, was first approved by FDA on Aug 31, 1995, with 6 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Aug 31, 1995 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Butalbital, Aspirin, Caffeine, And Codeine Phosphate325MG;50MG;40MG;30MG ยท capsule;oral | Aspirin; Butalbital; Caffeine; Codeine Phosphate | Discontinued |
| Sep 18, 2018 | Supplement 14REMS | Approved | None posted |
| Aug 29, 2002 | Supplement 6Labeling | Approved | None posted |
| Jul 31, 2002 | Supplement 5Manufacturing | Approved | None posted |
| Sep 5, 2001 | Supplement 3Manufacturing | Approved | None posted |
| Oct 29, 1998 | Supplement 2Manufacturing | Approved | None posted |
| Nov 27, 1996 | Supplement 1Manufacturing | Approved | None posted |
| Aug 31, 1995 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters